Tag: OHSU

All

Mole Mapper gives individuals the opportunity to contribute to a melanoma research initiative. Encourage your patients to download it today!

The injectable, known as Restylane Contour in the US, achieved a 94.4% responder rate at six months, with improvements sustained through 12 months.